Date | Price Target | Rating | Analyst |
---|---|---|---|
5/14/2024 | $8.50 | Underperform → Market Perform | Leerink Partners |
5/9/2024 | $14.00 → $8.75 | Buy → Hold | Jefferies |
3/7/2024 | $9.50 | Sell → Neutral | UBS |
12/12/2023 | $12.00 | Market Perform | TD Cowen |
6/20/2023 | $10.00 | Underperform | SVB Securities |
3/16/2023 | $15.00 | Neutral | Goldman |
12/13/2022 | $18.00 | Market Perform | CJS Securities |
12/8/2022 | $12.00 | Sell | UBS |
10-Q - Enhabit, Inc. (0001803737) (Filer)
8-K - Enhabit, Inc. (0001803737) (Filer)
8-K - Enhabit, Inc. (0001803737) (Filer)
Reiterates that Two Leading Proxy Advisory Firms Have Recommended Stockholders Support Meaningful Change to Enhabit's BoardReminds Stockholders that Enhabit Has Historically Made Excuses for Poor Performance and Empty PromisesUnderscores Opportunity Stockholders Have to Add Industry-Specific Expertise to Enhabit's Board at the Annual Meeting on July 25thAREX Capital Management, LP (together with its affiliates, "AREX"), the beneficial owner of approximately 4.9% of the outstanding common shares of Enhabit, Inc. (NYSE:EHAB) ("Enhabit" or the "Company"), today issued an open letter to its fellow stockholders asking them to address the deficiencies of Enhabit's current board of directors by ele
Enhabit, Inc. (NYSE:EHAB) ("Enhabit" or the "Company"), a leading home health and hospice provider, today announced certain unaudited preliminary results for the second quarter ended June 30, 2024. The Company plans to report actual second quarter 2024 financial results on Aug. 6, 2024, and host a webcast and conference call on Aug. 7, 2024. Unaudited Preliminary Results for the Second Quarter Ended June 30, 2024 Adjusted EBITDA* in the range of $24.5 million to $25.0 million Reduced bank debt by $15 million, including a $10 million payment on Enhabit's revolving credit facility 43% of Enhabit's non-Medicare visits shifting to payor innovation contracts at improved rates, an increase f
https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2F4b216008-24ac-4184-9324-3ce8da548a35.usrfiles.com%2Fugd%2F4b2160_2a4b9d87603040aca08fa852fe969a2d.pdf&esheet=54090927&newsitemid=20240705086860&lan=en-US&anchor=Enhabit%26%238217%3Bs+Excuses+and+Empty+Promises&index=1&md5=a39bf52df03457cf5c388c4f47b336bb
Enhabit, Inc. (NYSE:EHAB), ("Enhabit" or the "Company"), a leading home health and hospice care provider, today announced that Crissy Carlisle, chief financial officer, will step down from her role as CFO. Ms. Carlisle has agreed to facilitate a smooth transition of roles and responsibilities. Enhabit has initiated a comprehensive search to identify the Company's next chief financial officer. "Crissy has made important contributions to Enhabit since we became a public company just over two years ago," said Barb Jacobsmeyer, president and CEO of Enhabit. "Her deep commitment to our employees, patients, partners and stockholders, as well as her insights and financial acumen, have contribu
Company to host a conference call tomorrow, August 7, 2024, at 10 a.m. EDT Enhabit, Inc. (NYSE:EHAB), a leading home health and hospice care provider, today reported its results of operations for the second quarter ended June 30, 2024. "The second quarter marked our third sequential quarter demonstrating the success of our strategies," said Enhabit's President and Chief Executive Officer Barb Jacobsmeyer. "In our home health segment, our total admissions growth of 6.4% was driven by our payor innovation strategy and our focus on improved utilization of our clinical resources. In our hospice segment, we continued to make steady progress in growing our census, with average daily census in
Enhabit, Inc. (NYSE:EHAB) ("Enhabit" or the "Company"), a leading home health and hospice provider, today announced certain unaudited preliminary results for the second quarter ended June 30, 2024. The Company plans to report actual second quarter 2024 financial results on Aug. 6, 2024, and host a webcast and conference call on Aug. 7, 2024. Unaudited Preliminary Results for the Second Quarter Ended June 30, 2024 Adjusted EBITDA* in the range of $24.5 million to $25.0 million Reduced bank debt by $15 million, including a $10 million payment on Enhabit's revolving credit facility 43% of Enhabit's non-Medicare visits shifting to payor innovation contracts at improved rates, an incr
4 - Enhabit, Inc. (0001803737) (Issuer)
3 - Enhabit, Inc. (0001803737) (Issuer)
4 - Enhabit, Inc. (0001803737) (Issuer)
SC 13G/A - Enhabit, Inc. (0001803737) (Subject)
SC 13G/A - Enhabit, Inc. (0001803737) (Subject)
SC 13G/A - Enhabit, Inc. (0001803737) (Subject)
NEW YORK, Sept. 6, 2024 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, September 23, to coincide with the quarterly rebalance. The changes ensure each index is more representative of its market capitalization range. All companies being added to the S&P 500 are more representative of the large-cap market space, all companies being added to the S&P MidCap 400 are more representative of the mid-cap market space, and all companies being added to the S&P SmallCap 600 are more representative of the small-cap market space. The companies being removed from
Enhabit, Inc. (NYSE:EHAB), a leading home health and hospice provider, today announced its participation in two upcoming investor conferences. Enhabit's President and Chief Executive Officer Barb Jacobsmeyer and Chief Financial Officer Crissy Carlisle will participate in the following events: Jefferies Healthcare Services "Back to School" Summit and Bus Tour When: Aug. 28 Venue: 1 Hotel Nashville in Nashville, Tenn. 2024 Wells Fargo Healthcare Conference When: Investor meetings and a fireside chat on Sept. 5 Venue: Encore Boston Harbor in Boston, Mass. The fireside chat will be webcast live at 11 a.m. EDT and available for replay at https://investors.ehab.com under
Enhabit, Inc. (NYSE:EHAB), ("Enhabit" or the "Company"), a leading home health and hospice care provider, today announced that Crissy Carlisle, chief financial officer, will step down from her role as CFO. Ms. Carlisle has agreed to facilitate a smooth transition of roles and responsibilities. Enhabit has initiated a comprehensive search to identify the Company's next chief financial officer. "Crissy has made important contributions to Enhabit since we became a public company just over two years ago," said Barb Jacobsmeyer, president and CEO of Enhabit. "Her deep commitment to our employees, patients, partners and stockholders, as well as her insights and financial acumen, have contribu
Leerink Partners upgraded Enhabit Inc. from Underperform to Market Perform and set a new price target of $8.50
Jefferies downgraded Enhabit Inc. from Buy to Hold and set a new price target of $8.75 from $14.00 previously
UBS upgraded Enhabit Inc. from Sell to Neutral and set a new price target of $9.50
4 - Enhabit, Inc. (0001803737) (Issuer)
4 - Enhabit, Inc. (0001803737) (Issuer)
4 - Enhabit, Inc. (0001803737) (Issuer)
NEW YORK, Sept. 6, 2024 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, September 23, to coincide with the quarterly rebalance. The changes ensure each index is more representative of its market capitalization range. All companies being added to the S&P 500 are more representative of the large-cap market space, all companies being added to the S&P MidCap 400 are more representative of the mid-cap market space, and all companies being added to the S&P SmallCap 600 are more representative of the small-cap market space. The companies being removed from
Files Definitive Proxy Materials and Mails Letter to Stockholders AREX's Unqualified Slate of Nominees Risks Detracting from the Talent Currently on the Board Urges Stockholders to Vote "FOR" Only Enhabit's Nine Nominees on the YELLOW Proxy Card Enhabit, Inc. (NYSE:EHAB) ("Enhabit" or the "Company"), a leading home health and hospice provider, today announced that it has filed definitive proxy materials with the Securities and Exchange Commission in connection with its upcoming 2024 annual meeting of stockholders (the "2024 Annual Meeting") scheduled for July 25, 2024. Stockholders of record as of the close of business on June 5, 2024, are entitled to vote at the 2024 Annual Meeting.
Files Preliminary Proxy Statement; Elaborates on AREX Capital Management's Singular Focus in Demanding a Sale of the Company Enhabit, Inc. (NYSE:EHAB) ("Enhabit" or the "Company") today announced that it has filed its preliminary proxy materials with the Securities and Exchange Commission (the "SEC") in connection with its upcoming 2024 annual meeting of stockholders (the "2024 Annual Meeting"). The preliminary proxy statement is available on the Investor Relations section of the Enhabit website at investors.ehab.com. The Company is filing a preliminary proxy statement because AREX Capital Management, LP (together with its affiliates and associates, "AREX") has notified the Company that